Clinical trial
High PlatElet Inhibition With TicAgrelor to Improve Left Ventricular RemodeLING in Patients With ST-segment ElevAtion Myocardial Infarction: the HEALING-AMI Trial.
NCT02224534 is registered in ClinicalTrials.gov with Gyeongsang National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High PlatElet Inhibition With TicAgrelor to Improve Left Ventricular RemodeLING in Patients With ST-segment ElevAtion Myocardial Infarction: the HEALING-AMI Trial.
- Lead sponsor
- Gyeongsang National University Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 31, 2014
- Completion date
- December 31, 2017
- Enrollment
- 326 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.